What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
Thomas F. Lüscher mostly deals with Internal medicine, Endocrinology, Endothelium, Cardiology and Endothelial dysfunction.
Internal medicine is a component of his Myocardial infarction, Endothelin receptor, Coronary artery disease, Vascular smooth muscle and Blood pressure studies.
His Myocardial infarction research focuses on Stent and how it relates to Intravascular ultrasound.
His Endothelium research focuses on subjects like Tetrahydrobiopterin, which are linked to Superoxide.
Cardiology is frequently linked to Surgery in his study.
His Endothelial dysfunction study combines topics from a wide range of disciplines, such as Nitric Oxide Synthase Type III, Cholesterol, Lipoprotein, Microcirculation and Prostacyclin.
His most cited work include:
- Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial (1869 citations)
- Diabetes and Vascular Disease Pathophysiology, Clinical Consequences, and Medical Therapy: Part I (1357 citations)
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency (1149 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Endocrinology, Myocardial infarction and MEDLINE.
His study in Endothelium, Heart failure, Coronary artery disease, Endothelial dysfunction and Acute coronary syndrome is carried out as part of his studies in Internal medicine.
His Cardiology research incorporates themes from Surgery and Blood pressure.
His study on Endocrinology is mostly dedicated to connecting different topics, such as Endothelin receptor.
His Myocardial infarction study often links to related topics such as Stroke.
His study connects Intensive care medicine and MEDLINE.
He most often published in these fields:
- Internal medicine (67.55%)
- Cardiology (38.47%)
- Endocrinology (21.15%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (67.55%)
- Cardiology (38.47%)
- MEDLINE (18.91%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Cardiology, MEDLINE, Intensive care medicine and Myocardial infarction.
His work on Endocrinology expands to the thematically related Internal medicine.
His Cardiology study frequently links to related topics such as Hazard ratio.
His biological study deals with issues like Bioinformatics, which deal with fields such as Disease.
Thomas F. Lüscher interconnects Diabetes mellitus, Prospective cohort study and Cohort in the investigation of issues within Myocardial infarction.
His Coronary artery disease study frequently draws connections to adjacent fields such as Revascularization.
Between 2017 and 2021, his most popular works were:
- International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology (372 citations)
- International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management. (207 citations)
- Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis (142 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Thomas F. Lüscher focuses on Internal medicine, Cardiology, Myocardial infarction, MEDLINE and Heart failure.
Internal medicine connects with themes related to Endocrinology in his study.
Thomas F. Lüscher has researched Cardiology in several fields, including Clinical endpoint and Incidence.
His Myocardial infarction research includes elements of Diabetes mellitus, Prospective cohort study, Odds ratio and Hazard ratio.
His MEDLINE research incorporates elements of Takotsubo syndrome, Blood pressure and Intensive care medicine.
His research investigates the connection between Takotsubo syndrome and topics such as Clinical trial that intersect with problems in Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
